Very late presentation of fulminant myocardial immune-related toxicity in a patient on pembrolizumab

Authors

Mahmoud Ali, Advocate Aurora HealthFollow
Marc Atzenhoefer, Advocate Aurora HealthFollow
Kevin Bodker, Advocate Aurora HealthFollow
Tarek Ajam, Advocate Aurora HealthFollow
Daniel Johnsrud, Advocate Aurora HealthFollow
Zeinab Saleh, Advocate Aurora HealthFollow
Adil S. Wani, Advocate Aurora HealthFollow
Patrycja Galazka, Advocate Aurora HealthFollow
Tanvir Bajwa, Advocate Aurora HealthFollow
M Fuad Jan, Advocate Aurora HealthFollow

Recommended Citation

Ali M, Atzenhoefer M, Bodker K, et al. Very late presentation of fulminant myocardial immune-related toxicity in a patient on pembrolizumab. J Am Coll Cardiol. 2020;75(S11):3273.

Affiliations

Aurora Cardiovascular and Thoracic Services, Aurora St. Luke’s/Aurora Sinai Medical Centers,

Presentation Notes

Poster presented at: ACC.20 World Congress of Cardiology; March 30, 2020.

Document Type

Abstract